Systemic lupus erythematosus epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Systemic lupus erythematosus}}
{{Systemic lupus erythematosus}}


{{CMG}}; {{AE}} {{CZ}} {{RT}}
{{CMG}}; {{AE}} {{CZ}}; {{RT}}


==Overview==
==Overview==

Revision as of 13:31, 3 August 2012

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus epidemiology and demographics

on Systemic lupus erythematosus epidemiology and demographics

Systemic lupus erythematosus epidemiology and demographics in the news

Blogs onSystemic lupus erythematosus epidemiology and demographics

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

Epidemiology

Prevalence

  • Worldwide, a conservative estimate states that over 5 million people have lupus.
  • In the United States the prevalence of the disease is 25 per every 100,000. In the United States alone, it is estimated that between 270,000 and 1.5 million people have lupus, making it more common than cystic fibrosis or cerebral palsy.

Age

  • The prevalence of the disease is common in the young patient population even though it can occur at any age.

Gender

  • Lupus occurs in both men and women but young women of the childbearing age are nine times more often diagnosed than men.

Race

  • The disease appears to be more prevalent in women of African, Asian, Hispanic and Native American origin but this may be due to socioeconomic factors.
  • SLE occurs with much greater severity among African-American women, who suffer more severe symptoms as well as a higher mortality rate. [1]

References


Template:WH Template:WS